Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy
Clinical trial NCT00066508 · COMPLETED
Trial details
- NCT number
- NCT00066508
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2005-07-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.